Contribution of IL12A and IL12B Polymorphisms to the Risk of Cervical Cancer

Overview

Journal Pathol Oncol Res

Specialty Oncology

Date 2012 May 23

PMID 22614250

Citations 8

Authors

Andrzej Roszak

Adrianna Mostowska

Anna Sowinska

Margarita Lianeri

Pawel P Jagodzinski

Affiliations

Soon will be listed here.

Abstract

We studied the contribution of the IL12A 3'UTR G>A (rs568408) and IL12B 3'UTR A>C (rs3212227) polymorphisms to the risk of cervical cancer. These polymorphisms were genotyped in four hundred-five patients with cervical cancer and four hundred fifty unrelated healthy females from the Polish population. Logistic regression analysis adjusting for age, pregnancy, oral contraceptive use, tobacco smoking, and menopausal status revealed that the IL12B 3'UTR A>C polymorphism could be a genetic risk factor for cervical cancer. The adjusted odds ratio (OR) for patients with the A/C genotype vs A/A genotype was 1.557 (95 % CI = 1.173-2.066, p = 0.0178) and adjusted OR for the C/C or A/C genotype vs the A/A genotype was 1.635 (95 % CI = 1.241-2.153, p = 0.0125). However, logistic regression analysis did not show an association of the IL12A 3'UTR G>A polymorphism with cervical cancer development in the studied Polish population. Our studies confirmed that the IL12B 3'UTR A>C polymorphism may be a genetic risk factor for cervical cancer.

Citing Articles

Identification of an immune-related genes signature to predict risk of recurrence for patients with laryngeal squamous cell carcinoma.

Hong X, Li Y, Lv Q, An J, Liu Y, Wang X Int J Immunopathol Pharmacol. 2023; 37:3946320231172075.

PMID: 37073715 PMC: 10127216. DOI: 10.1177/03946320231172075.

A Meta-Analysis for Association of XRCC3 rs861539, MTHFR rs1801133, IL-6 rs1800795, IL-12B rs3212227, TNF-α rs1800629, and TLR9 rs352140 Polymorphisms with Susceptibility to Cervical Carcinoma.

Parsaeian S, Asadian F, Karimi-Zarchi M, Setayesh S, Javaheri A, Sadat Tabatabaie R Asian Pac J Cancer Prev. 2021; 22(11):3419-3431.

PMID: 34837895 PMC: 9068191. DOI: 10.31557/APJCP.2021.22.11.3419.

Association of IL-12B rs3212227 and IL-6 rs1800795 Polymorphisms with Susceptibility to Cervical Cancer: A Systematic Review and Meta-Analysis.

Karimi-Zarchi M, Abbasi H, Javaheri A, Hadadan A, Meibodi B, Sadat Tabatabaei R Asian Pac J Cancer Prev. 2020; 21(5):1197-1206.

PMID: 32458622 PMC: 7541893. DOI: 10.31557/APJCP.2020.21.5.1197.

A Functional Polymorphism in the Promoter Region of Interleukin-12B Increases the Risk of Colorectal Cancer.

Liu Y, Li B, Wang L, Kong D Biomed Res Int. 2020; 2020:2091781.

PMID: 32149085 PMC: 7054766. DOI: 10.1155/2020/2091781.

Association of Interleukin-12A rs568408 with Susceptibility to Asthma in Taiwan.

Shen T, Tsai C, Chang W, Wang S, Chao C, Hsiao C Sci Rep. 2017; 7(1):3199.

PMID: 28600552 PMC: 5466618. DOI: 10.1038/s41598-017-03523-0.

References

Trinchieri G . Interleukin-12 and the regulation of innate resistance and adaptive immunity. Nat Rev Immunol. 2003; 3(2):133-46. DOI: 10.1038/nri1001. View

Lan Q, Zheng T, Rothman N, Zhang Y, Wang S, Shen M . Cytokine polymorphisms in the Th1/Th2 pathway and susceptibility to non-Hodgkin lymphoma. Blood. 2006; 107(10):4101-8. PMC: 1895277. DOI: 10.1182/blood-2005-10-4160. View

Nanni P, Nicoletti G, De Giovanni C, Landuzzi L, Di Carlo E, Cavallo F . Combined allogeneic tumor cell vaccination and systemic interleukin 12 prevents mammary carcinogenesis in HER-2/neu transgenic mice. J Exp Med. 2001; 194(9):1195-205. PMC: 2195980. DOI: 10.1084/jem.194.9.1195. View

Lee K, Shen M, Chapman R, Yeager M, Welch R, He X . Polymorphisms in immunoregulatory genes, smoky coal exposure and lung cancer risk in Xuan Wei, China. Carcinogenesis. 2007; 28(7):1437-41. DOI: 10.1093/carcin/bgm030. View

Munoz N, Bosch F, de Sanjose S, Herrero R, Castellsague X, Shah K . Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Engl J Med. 2003; 348(6):518-27. DOI: 10.1056/NEJMoa021641. View

Indrova M, Bieblova J, Rossowska J, Kuropka P, Pajtasz-Piasecka E, Bubenik J . HPV 16-associated tumours: IL-12 can repair the absence of cytotoxic and proliferative responses of tumour infiltrating cells after chemotherapy. Int J Oncol. 2008; 34(1):173-9. View

Chen Y, Zheng T, Lan Q, Foss F, Kim C, Chen X . Cytokine polymorphisms in Th1/Th2 pathway genes, body mass index, and risk of non-Hodgkin lymphoma. Blood. 2010; 117(2):585-90. PMC: 3031482. DOI: 10.1182/blood-2010-07-295097. View

Kadish A, Timmins P, Wang Y, Ho G, Burk R, Ketz J . Regression of cervical intraepithelial neoplasia and loss of human papillomavirus (HPV) infection is associated with cell-mediated immune responses to an HPV type 16 E7 peptide. Cancer Epidemiol Biomarkers Prev. 2002; 11(5):483-8. View

Seegers D, Zwiers A, Strober W, Pena A, Bouma G . A TaqI polymorphism in the 3'UTR of the IL-12 p40 gene correlates with increased IL-12 secretion. Genes Immun. 2002; 3(7):419-23. DOI: 10.1038/sj.gene.6363919. View

10.

Colombo M, Trinchieri G . Interleukin-12 in anti-tumor immunity and immunotherapy. Cytokine Growth Factor Rev. 2002; 13(2):155-68. DOI: 10.1016/s1359-6101(01)00032-6. View

11.

Trinchieri G . Interleukin-12: a cytokine at the interface of inflammation and immunity. Adv Immunol. 1998; 70:83-243. DOI: 10.1016/s0065-2776(08)60387-9. View

12.

Mikyskova R, Indrova M, Simova J, Bieblova J, Bubenik J, Reinis M . Genetically modified tumour vaccines producing IL-12 augment chemotherapy of HPV16-associated tumours with gemcitabine. Oncol Rep. 2011; 25(6):1683-9. DOI: 10.3892/or.2011.1221. View

13.

Howell W, Turner S, Theaker J, Bateman A . Cytokine gene single nucleotide polymorphisms and susceptibility to and prognosis in cutaneous malignant melanoma. Eur J Immunogenet. 2003; 30(6):409-14. DOI: 10.1111/j.1365-2370.2003.00425.x. View

14.

Morahan G, McKinnon E, Berry J, Browning B, Julier C, Pociot F . Evaluation of IL12B as a candidate type I diabetes susceptibility gene using data from the Type I Diabetes Genetics Consortium. Genes Immun. 2009; 10 Suppl 1:S64-8. PMC: 2805152. DOI: 10.1038/gene.2009.94. View

15.

Nieters A, Yuan J, Sun C, Zhang Z, Stoehlmacher J, Govindarajan S . Effect of cytokine genotypes on the hepatitis B virus-hepatocellular carcinoma association. Cancer. 2005; 103(4):740-8. DOI: 10.1002/cncr.20842. View

16.

Giuliano A, Harris R, Sedjo R, Baldwin S, Roe D, Papenfuss M . Incidence, prevalence, and clearance of type-specific human papillomavirus infections: The Young Women's Health Study. J Infect Dis. 2002; 186(4):462-9. DOI: 10.1086/341782. View

17.

Noguchi Y, Jungbluth A, Richards E, Old L . Effect of interleukin 12 on tumor induction by 3-methylcholanthrene. Proc Natl Acad Sci U S A. 1996; 93(21):11798-801. PMC: 38138. DOI: 10.1073/pnas.93.21.11798. View

18.

Yilmaz V, Yentur S, Saruhan-Direskeneli G . IL-12 and IL-10 polymorphisms and their effects on cytokine production. Cytokine. 2005; 30(4):188-94. DOI: 10.1016/j.cyto.2005.01.006. View

19.

Arbyn M, Raifu A, Autier P, Ferlay J . Burden of cervical cancer in Europe: estimates for 2004. Ann Oncol. 2007; 18(10):1708-15. DOI: 10.1093/annonc/mdm079. View

20.

Davoodi-Semiromi A, Yang J, She J . IL-12p40 is associated with type 1 diabetes in Caucasian-American families. Diabetes. 2002; 51(7):2334-6. DOI: 10.2337/diabetes.51.7.2334. View